
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical
Society 3145882210.1021/acsomega.8b01030ArticleExtent of Helical Induction Caused by Introducing
α-Aminoisobutyric Acid into an Oligovaline Sequence Tsuji Genichiro †Misawa Takashi †Doi Mitsunobu ‡Demizu Yosuke *†† Division
of Organic Chemistry, National Institute
of Health Sciences, Kanagawa 210-9501, Japan‡ Osaka
University of Pharmaceutical Sciences, Osaka 569-1094, Japan* E-mail: demizu@nihs.go.jp. Phone &
Fax: +81-44-270-6578.14 06 2018 30 06 2018 3 6 6395 6399 17 05 2018 05 06 2018 Copyright © 2018 American Chemical
Society2018American Chemical
SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

The preferred conformations of a
dodecapeptide composed of l-valine (l-Val) and α-aminoisobutyric
acid (Aib)
residues, Boc-(l-Val-l-Val-Aib)4-OMe
(3), were analyzed in solution and in the crystalline
state. Peptide 3 predominantly folded into a mixture
of α- and 310-(P) helical structures
in solution and a (P) α helix in the crystalline
state.

document-id-old-9ao8b01030document-id-new-14ao-2018-01030hccc-price
==== Body
1 Introduction
In
proteins, helices are abundant and important secondary structures,
which recognize macromolecules, such as other proteins and DNA. Helical
peptides that mimic proteins are capable of inhibiting protein–protein
interactions, and a variety of helix-stabilizing methods have been
developed to aid the production of such peptides. As representative
techniques, the introduction of α,α-disubstituted α-amino
acids (dAA)1 or cyclic β-amino acids2 into short oligopeptides and side-chain stapling3 can all help to stabilize helical structures.
In particular, α-aminoisobutyric acid (Aib) is the simplest
dAA, and it is commonly used as a helical promoter.4 We have previously reported that the introduction of Aib
residues into natural amino acid sequences stabilized helical structures.
For example, the oligopeptides Boc-(l-Leu-l-Leu-Aib)n-OMe (n = 3 or 4) preferentially
form stable right-handed (P) helical structures.5,6 These peptides are able to act as organocatalysts for asymmetric
reaction, such as enantioselective epoxidation catalysts of α,β-unsaturated
ketones6 and Michael addition of a malonate.7 Furthermore, the amphipathic peptides R-(l-Xaa-l-Xaa-Aib)3-NH2 (R = FAM-β-Ala
and Xaa = Arg or R = H and Xaa = Lys) were also folded into stable
helical structures and were used as antimicrobial peptides8 and cell-penetrating peptides,9 respectively. In addition, we have recently reported that
the azidolysine (Azl)-based peptide Boc-(l-Azl-l-Azl-Aib)3-OMe formed a stable helical structure, and
the azide groups could be replaced with several functional groups
via click reactions without influencing the peptide’s helical
structure.10 Thus, the insertion of Aib
residues into α-amino acid-based oligopeptides is useful for
stabilizing helical structures and providing a variety of functions.
However, there have not been any reports about the secondary structural
changes that occur when Aib residues are introduced into oligopeptides
that form extended β-sheet structures. In general, oligopeptides
composed of β-branched amino acids, such as valine (Val) and
isoleucine (Ile), form β-sheet structures with extended conformations.
In particular, oligovalines have a strong tendency to form β-sheet
conformations.11 In this study, we designed
a dodecapeptide composed of l-Val and Aib residues, Boc-(l-Val-l-Val-Aib)4-OMe (3),
and analyzed its preferred conformations in solution and in the crystalline
state.

2 Results and Discussion
The dodecapeptide
Boc-(l-Val-l-Val-Aib)4-OMe (3) was synthesized using conventional solution-phase
methods according to a fragment condensation strategy, in which 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
(EDC) hydrochloride and 1-hydroxybenzotriazole (HOBt) hydrate were
used as coupling reagents. Briefly, alkaline hydrolysis of the tripeptide
Boc-l-Val-l-Val-Aib-OMe (1) afforded
the acid 1-COOH, whereas Boc deprotection by trifluoroacetic
acid furnished the amine 1-NH2. The amine 1-NH2 was coupled
with 1-COOH to give the hexapeptide Boc-(l-Val-l-Val-Aib)2-OMe (2). The dodecapeptide 3 was prepared in a manner similar to that used to prepare
the hexapeptide (Scheme 1).

Scheme 1 Synthesis of Peptides 1–3
The dominant conformations of the synthesized
peptides 1–3 in solution were analyzed based on
their Fourier transform infrared
(FT-IR), 1H nuclear magnetic resonance (NMR), and circular
dichroism (CD) spectra. Figure 1 shows the IR spectra of the tri- (1), hexa-
(2), and dodecapeptide (3) in the 3200–3500
cm–1 region (the amide A NH-stretching region) at
a peptide concentration of 5.0 mM in CDCl3 solution. In
the spectra, the weak bands in the 3425–3438 cm–1 region were assigned to free (solvated) peptide NH groups, and the
strong bands in the 3325–3340 cm–1 region
were assigned to peptide NH groups with N–H···O=C
intramolecular hydrogen bonds. These IR spectra are similar to those
of helical peptides containing Aib residues.12

Figure 1 IR
spectra of peptides 1 (green), 2 (blue),
and 3 (red) in CDCl3 solution (peptide concentration:
5.0 mM).

In the 1H NMR spectra
of the dodecapeptide 3, the N-terminal urethane-type
N(1)H proton signal was unambiguously
determined by the high-field position but the remaining eleven peptide
NH protons could not be assigned. Figure 2 shows a solvent perturbation experiment
involving the addition of the strong H-bond acceptor solvent dimethyl
sulfoxide (DMSO-d6) [0–10% (v/v)].
Two NH chemical shifts in the high-field positions were sensitive
to the addition of DMSO-d6. These results
are indicative of a 310- or α-helical structure in
solution.13

Figure 2 Plots of chemical shift
values of the NH protons of peptide 3 as a function of
the concentration of DMSO-d6 (v/v) in
CDCl3 solution (peptide concentration:
5.0 mM).

The CD spectra of the dodecapeptide 3 in 2,2,2-trifluoroethanol
(TFE) showed negative maxima at 207 and 222 nm indicating that 3 formed a right-handed (P) helical structure.
Judging from the R([θ]222/[θ]208) value,14 the secondary structure
of 3 (R = 0.64) was a mixture of α-
and 310-helical structures (Figure 3). This spectrum is similar to that of Boc-(l-Leu-l-Leu-Aib)4-OMe (R = 0.51).15

Figure 3 CD spectra of the dodecapeptide 3 (red) and Boc-(l-Leu-l-Leu-Aib)4-OMe (black) in TFE solution
(peptide concentration: 0.1 mM).

Peptide 3 formed good crystals for X-ray crystallographic
analysis after the slow evaporation of methanol/water at room temperature.
Its crystal and diffraction parameters, selected backbone and side-chain
torsion angles, and intra- and intermolecular hydrogen-bond parameters
are listed in the Supporting Information.16−19 The asymmetric unit in 3 contained two (P) α-helical structures with a flipped C-terminal Aib(12) residue
(Figure 4a). The conformations
of molecules A and B were well-matched,
except for small differences in their side-chain conformations (Figure 4b). The mean ϕ
and ψ torsion angles of the residues (2–11) were −63.1°
and −39.9° for A and −62.6° and
−40.7° for B, which are close to those of
an ideal (P) α-helix (−60° and
−45°, respectively). Regarding the intramolecular hydrogen
bonds in molecules A and B, eight i ← i + 4 type hydrogen bonds were
observed, respectively. In packing mode, molecules A and B were connected by intermolecular hydrogen bonds via methanol
molecules, forming chains with head-to-tail alignments (···A···A···A··· and ···B···B···B···).

Figure 4 (a) X-ray diffraction
structure of 3. The methanol
molecules have been omitted. (b) Superimposed structures of molecules A (green) and B (blue).

3 Conclusions
We designed and synthesized a
dodecapeptide-containing l-Val and Aib residues, Boc-(l-Val-l-Val-Aib)4-OMe (3),
to investigate the influence of the
helical promoter Aib on β-sheet structures. The conformation
of 3 was analyzed based on its FT-IR, 1H NMR,
and CD spectra in solution and X-ray diffraction analysis in the crystalline
state. Peptide 3 predominantly folded into a mixture
of α- and 310-(P) helical structures
in solution and a (P) α helix in the crystalline
state. Although oligopeptides composed of β-branched amino acids
form β-sheet structures with extended conformations, the insertion
of Aib residues into β-sheet-forming peptide sequences could
change the conformations of helical structures. Thus, we revealed
that the insertion of Aib residues into oligopeptides not only stabilized
their helical structures but also markedly altered their secondary
structures (from βsheets to helical structures). Not only helical
but also unique secondary structures will be created by the combination
of natural l- and/or d-amino acids and Aib residues,20 and these findings will be invaluable for the
de novo design of peptide-based organic and bioorganic molecules.

4 Experimental Section
4.1 General
1H and 13C NMR spectra
were recorded at 400 and 100 MHz in CDCl3 (tetramethylsilane
as an internal standard). FT-IR spectra were recorded at 1 cm–1 resolution, with an average of 256 scans used for
the CDCl3 solution method (0.1 mm path length for NaCl
cell). High-resolution mass spectra were recorded with LCMS-IT-TOF
spectrometer. CD spectra were recorded using a 1.0 mm path length
cell in TFE.

4.2 Synthesis of Tripeptide 1
The tripeptide 1 was prepared by conventional
solution-phase peptide synthesis
strategy. Colorless crystals; mp 177–179 °C; [α]D24 = −95.7
(c 0.25, CHCl3); IR (CDCl3,
cm–1): 3437, 2969, 2934, 2875, 1738, 1705, 1671; 1H NMR (400 MHz, CDCl3): δ 6.66 (s, 1H), 6.43
(d, J = 8.0 Hz, 1H), 4.99 (d, J =
7.2 Hz, 1H), 4.21–4.18 (m, 1H), 3.91 (dd, J = 6.8 Hz, 1H), 3.70 (s, 3H), 2.23–2.17 (m, 2H), 1.53 (s,
3H), 1.51 (s, 3H), 1.45 (s, 9H), 0.97 (d, J = 6.8
Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 174.6, 171.6,
167.0, 156.1, 80.4, 60.5, 58.3, 56.4, 52.5, 50.2, 30.3, 30.2, 28.3,
24.8, 24.7, 19.3, 19.2, 17.7, 17.5; [HR-ESI(+)-TOF] m/z: calcd for C20H37N3O6Na [M + Na]+, 438.2575; found, 438.2591.

4.3 Synthesis of Hexapeptide 2
A solution
of the tripeptide Boc-l-Val-l-Val-Aib-OMe (1) (415 mg, 1.0 mmol) and 1 M aqueous NaOH (2.0 mL, 2.0 mmol)
in MeOH (10 mL) was stirred at room temperature for 24 h. The solution
was neutralized with 1 M aqueous HCl and was extracted with AcOEt.
Being dried over Na2SO4 and removing the solvent
afforded the tripeptide-carboxylic acid 1-COOH, which
was used for the next reaction without further purification. Trifluoroacetic
acid (1 mL) was added to a solution of 1 (415 mg, 1.0
mmol) in CH2Cl2 (5 mL), and then the mixture
was stirred at room temperature for 5 h. Removing the solvent afforded
the crude N-terminal free tripeptide 1-NH2, which was used without further purification. A mixture of
EDC (230 mg, 1.2 mmol), HOBt (162 mg, 1.2 mmol), N,N-diisopropylethylamine (418 μL, 2.4 mmol),
the above 1-COOH (1.0 mmol), and the above 1-NH2 (1.0 mmol) in CH2Cl2 (10 mL) was stirred at room temperature for 3 days. The solution
was washed with 3% aqueous HCl, saturated aqueous NaHCO3, and brine, before being dried over Na2SO4. After removing the solvent, the residue was purified by column
chromatography on silica gel (n-hexane/AcOEt = 1:5)
to give the hexapeptide 2 in 46% yield. Colorless crystals;
mp 200–203 °C; [α]D24 = −27.4 (c 0.5, CHCl3); IR (CDCl3, cm–1): 3437, 3340,
2968, 2935, 2875, 1736, 1703, 1665; 1H NMR (400 MHz, CDCl3): δ 7.64 (s, 1H), 7.30 (d, J = 9.2
Hz, 1H), 7.17 (s, 1H), 6.93 (d, J = 6.8 Hz, 1H),
6.44 (d, J = 5.2 Hz, 1H), 5.01 (d, J = 2.6 Hz, 1H), 4.42 (dd, J = 8.8, 5.2 Hz, 1H),
4.18 (dd, J = 6.4, 4.4 Hz, 1H), 3.95 (dd, J = 4.4 Hz, 1H), 3.82 (dd, J = 4.4, 2.6
Hz, 1H), 3.68 (3H, s), 2.50–2.44 (m, 2H), 2.30–2.20
(m, 2H), 1.53 (3H, s), 1.52 (3H, s), 1.50 (9H, s), 1.50 (3H, s), 1.48
(3H, s), 1.06 (d, J = 6.8 Hz, 6H), 1.05–1.04
(m, 3H), 1.01 (d, J = 6.8 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H),
0.95 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ
175.6, 175.2, 172.1, 171.9, 170.9, 170.5, 157.0, 81.8, 62.1, 60.8,
60.0, 58.6, 57.1, 55.8, 52.0, 29.4, 29.2, 28.9, 28.2, 27.5, 25.2,
24.7, 23.7, 19.6, 19.3, 19.2, 18.0, 17.5, 17.4, 17.2; [HR-ESI(+)-TOF] m/z: calcd for C34H62N6O9Na [M + Na]+, 721.4470; found,
721.4502.

4.4 Synthesis of Dodecapeptide 3
The dodecapeptide 3 was prepared using a method similar
to that described for
the preparation of 2. Yield 35%; colorless crystals;
mp 302–304 °C; [α]D24 = −16.9 (c 0.5, CHCl3); IR (CDCl3, cm–1): 3425, 3325,
2967, 2936, 2876, 1734, 1703, 1656; 1H NMR (400 MHz, CDCl3): δ 7.80 (d, J = 4.8 Hz, 1H), 7.77
(s, 1H), 7.73 (s, 1H), 7.67 (d, J = 4.8 Hz, 1H),
7.53–7.51 (m, 3H), 7.21 (d, J = 5.6 Hz, 1H),
7.10 (d, J = 6.0 Hz, 1H), 7.03 (d, J = 7.6 Hz, 1H), 6.72 (br s, 1H), 5.39 (br s, 1H), 4.41 (dd, J = 9.0, 5.8 Hz, 1H), 4.25 (dd, J = 7.2,
5.6 Hz, 1H), 3.89–3.84 (m, 3H), 3.82–3.79 (m, 1H), 3.71–3.62
(m, 2H), 3.67 (s, 3H), 2.47–2.36 (m, 2H), 2.29–2.15
(m, 6H), 1.52–1.48 (m, 33H), 1.12–0.97 (m, 48H); 13C NMR (100 MHz, CDCl3): δ 175.9, 175.9,
175.5, 173.8, 173.8, 173.0, 172.7, 172.6, 172.3, 171.5, 171.0, 157.2,
81.7, 62.9, 62.7, 62.5, 62.3, 60.9, 60.7, 59.2, 57.0, 56.8, 56.6,
55.8, 51.9, 29.8, 29.6, 29.5, 29.2, 29.2, 28.9, 28.3, 27.5, 27.4,
25.2, 24.6, 23.4, 23.3, 23.0, 19.9, 19.7, 19.5, 19.4, 19.4, 19.3,
19.2, 19.1, 19.1, 19.0, 18.9, 18.5, 18.0, 18.0, 17.8; [HR-ESI(+)-TOF] m/z: calcd for C62H112N12O15Na [M + Na]+, 1287.8262; found,
1287.8333.

Supporting Information Available
The Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b01030.Crystallographic
data and copies of the 1H NMR and 13C NMR spectra
of the peptides (PDF)

Crystallographic data of peptide 3 (CIF)



Supplementary Material
ao8b01030_si_001.pdf

 ao8b01030_si_002.cif

 The authors
declare no competing financial interest.

Acknowledgments
This study
was supported, in part, by JSPS KAKENHI
grant number 17k08385 (Y.D.), by a grant from the Takeda Science Foundation
(Y.D.), a grant from the Terumo Life Science Foundation (Y.D.), a
grant from the Suzuken Memorial Foundation (Y.D.), and a grant from
the Naito Foundation (Y.D.).
==== Refs
References
a Crisma M. ; Moretto A. ; Peggion C. ; Panella L. ; Kaptein B. ; Broxterman Q. B. ; Formaggio F. ; Toniolo C. 
Chiral, fully extended
helical peptides . Amino Acids 
2011 , 41 , 629 –641 . 10.1007/s00726-011-0839-9 .21293888  b Tomsett M. ; Maffucci I. ; Le Bailly B. A. F. ; Byrne L. ; Bijvoets S. M. ; Lizio M. G. ; Raftery J. ; Butts C. P. ; Webb S. J. ; Contini A. ; Clayden J. 
A tendril
perversion in a helical oligomer: trapping and characterizing a mobile
screw-sense reversal . Chem. Sci. 
2017 , 8 , 3007 –3018 . 10.1039/c6sc05474a .28451368  c Eto R. ; Oba M. ; Ueda A. ; Uku T. ; Doi M. ; Matsuo Y. ; Tanaka T. ; Demizu Y. ; Kurihara M. ; Tanaka M. 
Diastereomeric
Right- and Left-Handed Helical Structures with Fourteen (R)-Chiral Centers . Chem.—Eur. J. 
2017 , 23 , 18120 –18124 . 10.1002/chem.201705306 .29134704  d Yamashita H. ; Oba M. ; Misawa T. ; Tanaka M. ; Hattori T. ; Naito M. ; Kurihara M. ; Demizu Y. 
A Helix-Stabilized Cell-Penetrating
Peptide as an Intracellular Delivery Tool . ChemBioChem 
2016 , 17 , 137 –140 . 10.1002/cbic.201500468 .26560998  e Yamashita H. ; Demizu Y. ; Misawa T. ; Shoda T. ; Kurihara M. 
Synthesis
of a bis-cationic α,α-disubstituted amino acid (9-amino-bispidine-9-carboxylic
acid) and its effects on the conformational properties of peptides . Tetrahedron 
2015 , 71 , 2241 –2245 . 10.1016/j.tet.2015.02.076 . f Kobayashi H. ; Misawa T. ; Matsuno K. ; Demizu Y. 
Preorganized
Cyclic α,α-Disubstituted α-Amino Acids Bearing Functionalized
Side Chains That Act as Peptide-Helix Inducers . J. Org. Chem. 
2017 , 82 , 10722 –10726 . 10.1021/acs.joc.7b01946 .28915041 
a Gellman S. H. 
Foldamers: A Manifesto . Acc.
Chem. Res. 
1998 , 31 , 173 –180 . 10.1021/ar960298r . b Shin Y.-H. ; Gellman S. H. 
Impact of Backbone Pattern and Residue
Substitution on Helicity in α/β/γ-Peptides . J. Am. Chem. Soc. 
2018 , 140 , 1394 –1400 . 10.1021/jacs.7b10868 .29350033  c Cheng R. P. ; Gellman S. H. ; DeGrado W. F. 
β-Peptides:
From Structure to Function . Chem. Rev. 
2001 , 101 , 3219 –3232 . 10.1021/cr000045i .11710070  d Seebach D. ; Beck A. K. ; Bierbaum D. J. 
The World of β- and γ-Peptides
Comprised of Homologated Proteinogenic Amino Acids and Other Components . Chem. Biodiversity 
2004 , 1 , 1111 –1239 . 10.1002/cbdv.200490087 . e Goodman C.
M. ; Choi S. ; Shandler S. ; DeGrado W. F. 
Foldamers as versatile frameworks
for the design and evolution of function . Nat.
Chem. Biol. 
2007 , 3 , 252 –262 . 10.1038/nchembio876 .17438550 
a Kim Y.-W. ; Grossmann T. N. ; Verdine G. L. 
Synthesis of all-hydrocarbon
stapled α-helical peptides by ring-closing olefin metathesis . Nat. Protoc. 
2011 , 6 , 761 –771 . 10.1038/nprot.2011.324 .21637196  b Moellering R. E. ; Cornejo M. ; Davis T. N. ; Del Bianco C. ; Aster J. C. ; Blacklow S. C. ; Kung A. L. ; Gilliland D. G. ; Verdine G. L. ; Bradner J. E. 
Direct inhibition
of the NOTCH transcription factor complex . Nature 
2009 , 462 , 182 –188 . 10.1038/nature08543 .19907488  c Oba M. ; Kunitake M. ; Kato T. ; Ueda A. ; Tanaka M. 
Enhanced and
Prolonged Cell-Penetrating Abilities of Arginine-Rich Peptides by
Introducing Cyclic α,α-Disubstituted α-Amino Acids
with Stapling . Bioconjugate Chem. 
2017 , 28 , 1801 –1806 . 10.1021/acs.bioconjchem.7b00190 . d LaRochelle J. R. ; Cobb G. B. ; Steinauer A. ; Rhoades E. ; Schepartz A. 
Fluorescence Correlation Spectroscopy
Reveals Highly Efficient Cytosolic Delivery of Certain Penta-Arg Proteins
and Stapled Peptides . J. Am. Chem. Soc. 
2015 , 137 , 2536 –2541 . 10.1021/ja510391n .25679876  e Demizu Y. ; Yamagata N. ; Nagoya S. ; Sato Y. ; Doi M. ; Tanaka M. ; Nagasawa K. ; Okuda H. ; Kurihara M. 
Enantioselective
epoxidation of α,β-unsaturated ketones catalyzed by stapled
helical L-Leu-based peptides . Tetrahedron 
2011 , 67 , 6155 –6165 . 10.1016/j.tet.2011.06.075 .
a Lister F. G. A. ; Le Bailly B. A. F. ; Webb S. J. ; Clayden J. 
Ligand-modulated
conformational switching in a fully synthetic membrane-bound receptor . Nat. Chem. 
2017 , 9 , 420 –425 . 10.1038/nchem.2736 . b Crisma M. ; Formaggio F. ; Moretto A. ; Toniolo C. 
Peptide helices
based on α-amino acids . Biopolymers 
2006 , 84 , 3 –12 . 10.1002/bip.20357 .16123990  c Tonlolo C. ; Benedetti E. 
Trends Biochem Sci. 
1991 , 16 , 350 –353 . 10.1016/0968-0004(91)90142-i .1949158  d Karle I. L. ; Balaram P. 
Structural characteristics of α-helical
peptide molecules containing Aib residues . Biochemistry 
1990 , 29 , 6747 –6756 . 10.1021/bi00481a001 .2204420  e Ousaka N. ; Takeyama Y. ; Iida H. ; Yashima E. 
Chiral information
harvesting in dendritic metallopeptides . Nat.
Chem. 
2011 , 3 , 856 –861 . 10.1038/nchem.1146 .22024881  f Tsuchiya K. ; Numata K. 
Chemoenzymatic synthesis of polypeptides
containing the unnatural amino acid 2-aminoisobutyric acid . Chem. Commun. 
2017 , 53 , 7318 –7321 . 10.1039/c7cc03095a . g Demizu Y. ; Doi M. ; Sato Y. ; Tanaka M. ; Okuda H. ; Kurihara M. 
Screw-Sense Control
of Helical Oligopeptides Containing Equal Amounts of L- and D-Amino
Acids . Chem.—Eur. J. 
2011 , 17 , 11107 –11109 . 10.1002/chem.201101809 .21922545 
Demizu Y. ; Doi M. ; Kurihara M. ; Okuda H. ; Nagano M. ; Suemune H. ; Tanaka M. 
Conformational studies on peptides containing α,α-disubstituted
α-amino acids: chiral cyclic α,α-disubstituted α-amino
acid as an α-helical inducer . Org. Biomol.
Chem. 
2011 , 9 , 3303 –3312 . 10.1039/c0ob01146k .21437330 
Nagano M. ; Doi M. ; Kurihara M. ; Suemune H. ; Tanaka M. 
Stabilized α-Helix-Catalyzed
Enantioselective Epoxidation of α,β-Unsaturated Ketones . Org. Lett. 
2010 , 12 , 3564 –3566 . 10.1021/ol101435w .20604529 
Akagawa K. ; Sakai N. ; Kudo K. 
Histidine-Containing
Peptide Catalysts
Developed by a Facile Library Screening Method . Angew. Chem., Int. Ed. 
2015 , 54 , 1822 –1826 . 10.1002/anie.201410268 .
Misawa T. ; Imamura M. ; Ozawa Y. ; Haishima K. ; Kurihara M. ; Kikuchi Y. ; Demizu Y. 
Development of helix-stabilized antimicrobial
peptides composed of lysine and hydrophobic α,α-disubstituted
α-amino acid residues . Bioorg. Med. Chem.
Lett. 
2017 , 27 , 3950 –3953 . 10.1016/j.bmcl.2017.07.074 .28789896 
Yamashita H. ; Demizu Y. ; Shoda T. ; Sato Y. ; Oba M. ; Tanaka M. ; Kurihara M. 
Amphipathic
short helix-stabilized
peptides with cell-membrane penetrating ability . Bioorg. Med. Chem. 
2014 , 22 , 2403 –2408 . 10.1016/j.bmc.2014.03.005 .24661993 
Misawa T. ; Kanda Y. ; Demizu Y. 
Rational Design
and Synthesis of
Post-Functionalizable Peptide Foldamers as Helical Templates . Bioconjugate Chem. 
2017 , 28 , 3029 –3035 . 10.1021/acs.bioconjchem.7b00621 .
a Balcerski J. S. ; Pysh E. S. ; Bonora G. M. ; Toniolo C. 
Vacuum ultraviolet
circular dichroism of β-forming
alkyl oligopeptides . J. Am. Chem. Soc. 
1976 , 98 , 3470 –3473 . 10.1021/ja00428a013 .1270701  b Baron M. H. ; De Loze C. ; Toniolo C. ; Fasman G. D. 
Infrared
and Raman study in the solid state of fully protected, monodispersed
homooligopeptides of L-valine, L-isoleucine, and L-phenylalanine . Biopolymers 
1979 , 18 , 411 –424 . 10.1002/bip.1979.360180216 . c Toniolo C. 
Structural Role of Valine and Isoleucine Residues in
Proteins. A Proposal . Macromolecules 
1978 , 11 , 437 –438 . 10.1021/ma60062a033 . d Toniolo C. ; Bonora G. M. ; Mutter M. 
Conformations of poly(ethylene
glycol) bound homooligo-L-alanines and -L-valines in aqueous solution . J. Am. Chem. Soc. 
1979 , 101 , 450 –454 . 10.1021/ja00496a030 . e Toniolo C. ; Bonora G. M. ; Salardi S. 
Study of the relationship
between conformation and nature of side chains in linear oligopeptides:
homologous series derived from β-branched amino acid residues . Int. J. Biol. Macromol. 
1981 , 3 , 377 –383 . 10.1016/0141-8130(81)90093-3 . f Narayanan C. ; Dias C. L. 
Hydrophobic interactions and hydrogen
bonds in β-sheet formation . J. Chem. Phys. 
2013 , 139 , 115103 10.1063/1.4821596 .24070311 
a Crisma M. ; Bonora G. M. ; Toniolo C. ; Benedetti E. ; Bavoso A. ; Di Blasio B. ; Pavone V. ; Pedone C. 
Structural
versatility of peptides
from Cα,α-dialkylated glycines: an infrared absorption
and 1H n.m.r. study of homopeptides from 1-aminocyclopentane-1-carboxylic
acid . Int. J. Biol. Macromol. 
1988 , 10 , 300 –304 . 10.1016/0141-8130(88)90008-6 . b Benedetti E. ; Barone V. ; Bavoso A. ; Di Blasio B. ; Lelj F. ; Pavone V. ; Pedone C. ; Bonora G. M. ; Toniolo C. ; Leplawy M. T. ; Kaczmarek K. ; Redlinski A. 
Structural versatility of peptides from Cαα-dialkylated
glycines. I. A conformational energy computation and x-ray diffraction
study of homo-peptides from Cα,α-diethylglycine . Biopolymers 
1988 , 27 , 357 –371 . 10.1002/bip.360270302 . c Toniolo C. ; Bonora G. M. ; Bavoso A. ; Benedetti E. ; Di Blasio B. ; Pavone V. ; Pedone C. ; Barone V. ; Lelj F. ; Leplawy M. T. ; Kaczmarek K. ; Redlinski A. 
Structural versatility of peptides from C?,?-dialkylated
glycines. II. An IR absorption and1H-nmr study of homo-oligopeptides
from Cα,α-diethylglycine . Biopolymers 
1988 , 27 , 373 –379 . 10.1002/bip.360270303 .
a Bonora G. M. ; Toniolo C. ; Di Blasio B. ; Pavone V. ; Pedone C. ; Benedetti E. ; Lingham I. ; Hardy P. 
Folded and extended structures of
homooligopeptides from α,α-dialkylated α-amino acids.
An infrared absorption and proton nuclear magnetic resonance study . J. Am. Chem. Soc. 
1984 , 106 , 8152 –8156 . 10.1021/ja00338a025 . b Toniolo C. ; Bonora G. M. ; Barone V. ; Bavoso A. ; Benedetti E. ; Di Blasio B. ; Grimaldi P. ; Lelj F. ; Pavone V. ; Pedone C. 
Conformation
of pleionomers of α-aminoisobutyric acid . Macromolecules 
1985 , 18 , 895 –902 . 10.1021/ma00147a013 . c Demizu Y. ; Doi M. ; Kurihara M. ; Maruyama T. ; Suemune H. ; Tanaka M. 
One-Handed Helical Screw Direction
of Homopeptide Foldamer Exclusively Induced by Cyclic α-Amino
Acid Side-Chain Chiral Centers . Chem.—Eur.
J. 
2012 , 18 , 2430 –2439 . 10.1002/chem.201102902 .22267127 
a Toniolo C. ; Polese A. ; Formaggio F. ; Crisma M. ; Kamphuis J. 
Circular Dichroism Spectrum of a
Peptide 310-Helix . J. Am. Chem. Soc. 
1996 , 118 , 2744 –2745 . 10.1021/ja9537383 . b Yoder G. ; Polese A. ; Silva R. A. G. D. ; Formaggio F. ; Crisma M. ; Broxterman Q. B. ; Kamphuis J. ; Toniolo C. ; Keiderling T. A. 
Conformational
Characterization of Terminally Blockedl-(αMe)Val Homopeptides
Using Vibrational and Electronic Circular Dichroism. 310-Helical Stabilization by Peptide–Peptide Interaction . J. Am. Chem. Soc. 
1997 , 119 , 10278 –10285 . 10.1021/ja971392l . c Mammi S. ; Rainaldi M. ; Bellanda M. ; Schievano E. ; Peggion E. ; Broxterman Q. B. ; Formaggio F. ; Crisma M. ; Toniolo C. 
Concomitant Occurrence
of Peptide 310- and α-Helices Probed by NMR . J. Am. Chem. Soc. 
2000 , 122 , 11735 –11736 . 10.1021/ja002710a .
Demizu Y. ; Okitsu K. ; Yamashita H. ; Doi M. ; Misawa T. ; Oba M. ; Tanaka M. ; Kurihara M. 
α-Helical
Structures of Oligopeptides
with an Alternating l-Leu-Aib Segment . Eur.
J. Org. Chem. 
2016 , 2815 –2820 . 10.1002/ejoc.201600327 .
See Supporting Information.


Sheldrick G. M.  Program for Crystal
Structure Refinement (SHELXL 97) ; University
of Göttingen : Germany , 1997 .
Beurskens P. T. ; Admiraal G. ; Beurskens G. ; Bosman W. P. ; Gelder R. D. ; Israel R. ; Smits J.
M. M.  The DIRDIF-99 Program
System, Technical Report of the Crystallography Laboratory ; University of Nijmegen : The Netherlands , 1994 .
CCDC-1837130 contains the supplementary crystallographic data for
this paper . These data can be obtained free of charge
at www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre , 12, Union Road, Cambridge CB2 1EZ, UK; Fax: (+44) 1223-336-033;
or deposit@ccdc.cam.ac.uk).
a Demizu Y. ; Nagoya S. ; Doi M. ; Sato Y. ; Tanaka M. ; Kurihara M. 
Twisted Structure of
a Cyclic Hexapeptide Containing a Combination of Alternating l-Leu-d-Leu-Aib
Segments . J. Org. Chem. 
2012 , 77 , 9361 –9365 . 10.1021/jo301509c .23006337  b Demizu Y. ; Yamashita H. ; Yamazaki N. ; Sato Y. ; Doi M. ; Tanaka M. ; Kurihara M. 
Oligopeptides with Equal Amounts
of l- and d-Amino Acids May Prefer a Helix Screw Sense . J. Org. Chem. 
2013 , 78 , 12106 –12113 . 10.1021/jo402133e .24191707  c Demizu Y. ; Yamashita H. ; Doi M. ; Misawa T. ; Oba M. ; Tanaka M. ; Kurihara M. 
Topological
Study of the Structures of Heterochiral Peptides Containing Equal
Amounts of l-Leu and d-Leu . J. Org. Chem. 
2015 , 80 , 8597 –8603 . 10.1021/acs.joc.5b01541 .26274390

